Destiny Pharma Share Discussion Threads

[aspringo] 14/8/2019 08:31

Just my tuppence worth on this share.I'm foolishly topping up and 3 of the purchase made today are mine tjough showing as sales.As far as i can see the story hasnt changed. So far delivered exactly as promised but now the share price is at a fraction of the IPO.Someone may know whats going on, but until then I'll take a chance and keep accumalating.Apologies for my naivety. Good luck all

[gaiusgracchus] 27/5/2019 22:11

Interesting what you say about the length of time this company has taken to get to where it is. I bought some of these after IPO. Not at the top thank goodness but still, I'm down a fair bit. I've subsequently decided to stop investing in biotech stocks. Just don't have the insight required. This doesn't add much to the discussion on Destiny (I'm still holding) but I wish I knew how to figure out if the drug is likely to be successful - in which case we should be piling in - or if it's going to be a dud. I don't know...clearly.

[jack jebb] 16/4/2019 10:23

First bought into this pre IPO over 10 years ago. Its been a long time developing this so called super drug. Would see it 20 bag and a lot more if it did, but after all this time, I have strong doubts.

[edmonda] 16/4/2019 10:15

updated Equity Development research following FY18 results reiterates attractions of their novel antimicrobials pipeline and raises fair value level .

Note freely available here:

[okidokicoki] 28/1/2019 09:42

Bought in here on Friday looks very a interesting company . This drug could revolutionise the antibiotics industry and trails seem to be going well . Sky was pushing this on the IPO so think they will be intrested in it. Never bought on a IPO and have been watching it for over a year . Think this has bottomed and starting to find some traction . GL DYOR

[crowyogapose] 08/1/2019 07:43

Looks like it will be bust soon enough

[superadams] 25/10/2018 22:08

If there is any value here and China Medical bid, try and take paper. They have been a 20 bagger pour moi !

[opodio] 25/10/2018 20:56

15p target

[edmonda] 05/10/2018 11:54

new analysis on pipeline's development and expansion, with increased fair value as a result (a multiple of current share price). Plenty of news expected in coming weeks, too.

Note freely accessible here:

[mikeh30] 05/9/2018 11:14

https://www.edisoninvestmentresearch.com/research/report/destiny-pharma/preview/?utm_source=edison&utm_medium=EQUISOLVE_press_release&utm_campaign=DEST_04092018

[edmonda] 13/8/2018 13:26

Clinical progress with XF drug platform ;
Recently, positive results from a blinded, placebo-controlled Phase I dermal irritancy study of lead product XF-73 in aqueous solution, showed that high concentrations of XF-73 applied topically to intact and abraded skin had a ‘similar irritancy potential to water’. Pharmacokinetic sampling confirmed that XF-73 was not absorbed into the bloodstream of volunteers, supporting the drug’s safety profile and that of other XF drugs, in treating and preventing dermal infections.
The data helps to pave the way for a Phase IIb study start in a gel formulation of XF-73 in the new FDA indication for prevention of post-surgical Staphylococcus aureus infection, due to be launched on completion of a second standard dermal safety study of the gel formulation of XF-73 in H2’18.
Safety study results also complement the existing strong body of data on XF-73, including its ability to rapidly kill bacteria, and so reducing the potential for AMR to develop, compared to other antimicrobials tested. The data will further assist DEST in prioritising its pipeline that contains three other preclinical candidates.
Read the full note here ..

[superadams] 30/12/2017 10:39

Guys, I am following this only because I hold China Medical Systems Holdings which is a 26 bagger for me over the last decade. They are a very shrewd outfit but don't know whether this is good or bad for Dest.

[kop202] 28/12/2017 12:15

Something doesn't small right?

[opodio] 21/11/2017 10:15

Looks an AIM scam

[albanyvillas] 02/11/2017 11:01

Up 10p were on our way to a doubling imho i hope

[albanyvillas] 02/11/2017 10:44

Dirty and sweet

[albanyvillas] 02/11/2017 10:41

Nice to see the 330p price target from broker

[albanyvillas] 02/11/2017 10:39

Houston this is Houston you read me

We have launched a satellite

[albanyvillas] 02/11/2017 10:19

Northwards horatio

[dewtrader] 02/11/2017 10:11

Destiny Pharma (BUY) – Prevention better than cure
DEST LN (129p, TP 330p), Market Cap: £55m
(Corporate Stock)

Destiny Pharma’s lead programme is a novel anti-microbial targeting nasal de-colonisation of patients prior to surgery who harbour the potentially dangerous bacteria Staphylococcus aureus including the superbug MRSA. It is well documented that the majority of post-surgical infections are caused by a patient’s own bacteria principally residing in nasal passages. Consequently, new guidelines have emerged which recommend nasal de-colonisation prior to high-risk surgeries but the most widely used antibiotic suffers from significant limitations preventing widespread use. Destiny is developing a potent antimicrobial (XF-73) with several key attributes that suggest it could be optimally positioned to be the leader in a new FDA indication of prevention of post-surgical Staphylococcal infections. Clinical data has been persuasive providing a rapid bacterial kill combined with an unmatched resistance profile.

[jonwig] 08/10/2017 12:08

rackers - not quite ...

It's a binary bet, and to a non-specialist odds would be about 9:1 against success (statistical analysis of early-stage pharma without looking under the bonnet). But someone with subject knowledge can improve his odds selectively by looking at results to date and the people involved. For example, CEO Neil Clark was involved with steering CeNeS Pharma from 20 years ago. So weeding out the less likely candidates could shorten the odds to maybe 5:1. A dozen such companies invested in over a period could produce decent profits.

I wouldn't follow someone like Woodford, who seems to invest in every IPO! And I've already given my reasons for leaving it alone. however, DrMaccers (who might be in the business) has convinced me of the best strategy here.

[rackers1] 08/10/2017 08:42

How anyone can invest in such an illiquid stock needs help.Not something any sane investor would touch I feel.

[drmaccers] 03/10/2017 21:56

This needs to get past 2b before it's investible in really. Then it'll need a lot of cash for p3.Interesting but not more at this point in time or price